SKYE Annual Current Liabilities
$13.90 M
+$1.78 M+14.70%
01 December 2023
Summary:
As of February 5, 2025, SKYE annual total current liabilities is $13.90 million, with the most recent change of +$1.78 million (+14.70%) on December 1, 2023. During the last 3 years, it has risen by +$13.11 million (+1665.88%). SKYE annual current liabilities is now -12.79% below its all-time high of $15.94 million, reached on December 1, 2018.SKYE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SKYE Quarterly Current Liabilities
$5.62 M
-$8.70 M-60.73%
01 September 2024
Summary:
As of February 5, 2025, SKYE quarterly total current liabilities is $5.62 million, with the most recent change of -$8.70 million (-60.73%) on September 1, 2024. Over the past year, it has dropped by -$10.18 million (-64.41%). SKYE quarterly current liabilities is now -80.41% below its all-time high of $28.71 million, reached on March 1, 2019.SKYE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SKYE Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.7% | -64.4% |
| 3 y3 years | +1665.9% | -8.5% |
| 5 y5 years | -12.8% | -8.5% |
SKYE Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +255.3% | -64.4% | +43.8% |
| 5 y | 5-year | at high | +1665.9% | -64.4% | +614.5% |
| alltime | all time | -12.8% | >+9999.0% | -80.4% | >+9999.0% |
Skye Bioscience Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.62 M(-60.7%) |
| June 2024 | - | $14.32 M(-9.4%) |
| Mar 2024 | - | $15.80 M(+13.7%) |
| Dec 2023 | $13.90 M(+14.7%) | $13.90 M(+1.3%) |
| Sept 2023 | - | $13.72 M(+39.7%) |
| June 2023 | - | $9.82 M(+4.8%) |
| Mar 2023 | - | $9.37 M(-22.7%) |
| Dec 2022 | $12.12 M(+209.8%) | $12.12 M(+97.2%) |
| Sept 2022 | - | $6.15 M(+17.4%) |
| June 2022 | - | $5.24 M(+25.2%) |
| Mar 2022 | - | $4.18 M(+6.9%) |
| Dec 2021 | $3.91 M(+397.0%) | $3.91 M(+160.5%) |
| Sept 2021 | - | $1.50 M(-3.0%) |
| June 2021 | - | $1.55 M(+11.8%) |
| Mar 2021 | - | $1.38 M(+75.9%) |
| Dec 2020 | $787.20 K(-18.9%) | $787.20 K(-35.0%) |
| Sept 2020 | - | $1.21 M(-43.8%) |
| June 2020 | - | $2.16 M(+29.3%) |
| Mar 2020 | - | $1.67 M(+71.7%) |
| Dec 2019 | $970.80 K(-93.9%) | $970.80 K(-93.2%) |
| Sept 2019 | - | $14.26 M(+28.5%) |
| June 2019 | - | $11.10 M(-61.3%) |
| Mar 2019 | - | $28.71 M(+80.1%) |
| Dec 2018 | $15.94 M | $15.94 M(+40.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $11.32 M(+10.0%) |
| June 2018 | - | $10.29 M(+3088.0%) |
| Mar 2018 | - | $322.70 K(-60.0%) |
| Dec 2017 | $806.00 K(+21.8%) | $806.00 K(-51.3%) |
| Sept 2017 | - | $1.66 M(+39.4%) |
| June 2017 | - | $1.19 M(+59.2%) |
| Mar 2017 | - | $746.80 K(+12.8%) |
| Dec 2016 | $662.00 K(+13.8%) | $662.00 K(-21.3%) |
| Sept 2016 | - | $841.30 K(+71.3%) |
| June 2016 | - | $491.00 K(+0.2%) |
| Mar 2016 | - | $490.00 K(-15.8%) |
| Dec 2015 | $581.90 K(-27.4%) | $581.90 K(-6.1%) |
| Sept 2015 | - | $619.70 K(-63.1%) |
| June 2015 | - | $1.68 M(+108.5%) |
| Mar 2015 | - | $805.50 K(+0.5%) |
| Dec 2014 | $801.10 K(+1185.9%) | $801.10 K(+129.2%) |
| Sept 2014 | - | $349.50 K(+703.4%) |
| July 2014 | - | $43.50 K(-11.8%) |
| Apr 2014 | - | $49.30 K(-8.4%) |
| Jan 2014 | - | $53.80 K(-13.6%) |
| Oct 2013 | $62.30 K(+1348.8%) | $62.30 K(-3.0%) |
| July 2013 | - | $64.20 K(+21.4%) |
| Apr 2013 | - | $52.90 K(+1130.2%) |
| Oct 2012 | $4300.00 | $4300.00 |
FAQ
- What is Skye Bioscience annual total current liabilities?
- What is the all time high annual current liabilities for Skye Bioscience?
- What is Skye Bioscience annual current liabilities year-on-year change?
- What is Skye Bioscience quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Skye Bioscience?
- What is Skye Bioscience quarterly current liabilities year-on-year change?
What is Skye Bioscience annual total current liabilities?
The current annual current liabilities of SKYE is $13.90 M
What is the all time high annual current liabilities for Skye Bioscience?
Skye Bioscience all-time high annual total current liabilities is $15.94 M
What is Skye Bioscience annual current liabilities year-on-year change?
Over the past year, SKYE annual total current liabilities has changed by +$1.78 M (+14.70%)
What is Skye Bioscience quarterly total current liabilities?
The current quarterly current liabilities of SKYE is $5.62 M
What is the all time high quarterly current liabilities for Skye Bioscience?
Skye Bioscience all-time high quarterly total current liabilities is $28.71 M
What is Skye Bioscience quarterly current liabilities year-on-year change?
Over the past year, SKYE quarterly total current liabilities has changed by -$10.18 M (-64.41%)